These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28126589)

  • 41. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.
    Kim JS; Park IS; Park HE; Kim SY; Yun JA; Jung CK; Sung HY; Lee JK; Kang WK
    Neurol Sci; 2017 Jan; 38(1):171-179. PubMed ID: 27803984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients.
    Vascellari S; Orrù CD; Groveman BR; Parveen S; Fenu G; Pisano G; Piga G; Serra G; Oppo V; Murgia D; Perra A; Angius F; Hughson AG; Haigh CL; Manzin A; Cossu G; Caughey B
    PLoS Pathog; 2023 Jun; 19(6):e1011456. PubMed ID: 37390080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.
    Hilton D; Stephens M; Kirk L; Edwards P; Potter R; Zajicek J; Broughton E; Hagan H; Carroll C
    Acta Neuropathol; 2014 Feb; 127(2):235-41. PubMed ID: 24240814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls.
    Antunes L; Frasquilho S; Ostaszewski M; Weber J; Longhino L; Antony P; Baumuratov A; Buttini M; Shannon KM; Balling R; Diederich NJ
    Mov Disord; 2016 Oct; 31(10):1567-1570. PubMed ID: 27324838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-synuclein in salivary gland as biomarker for Parkinson's disease.
    Campo F; Carletti R; Fusconi M; Pellicano C; Pontieri FE; Di Gioia CR; de Vincentiis M
    Rev Neurosci; 2019 Jul; 30(5):455-462. PubMed ID: 30471223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
    Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K
    Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
    Kramer ML; Behrens C; Schulz-Schaeffer WJ
    Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
    Chahine LM; Beach TG; Brumm MC; Adler CH; Coffey CS; Mosovsky S; Caspell-Garcia C; Serrano GE; Munoz DG; White CL; Crary JF; Jennings D; Taylor P; Foroud T; Arnedo V; Kopil CM; Riley L; Dave KD; Mollenhauer B;
    Neurology; 2020 Sep; 95(9):e1267-e1284. PubMed ID: 32747521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lewy pathological study on α-synuclein in gastrointestinal tissues of prodromal Parkinson's disease.
    Lu QB; Zhu ZF; Zhang HP; Luo WF
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1514-1521. PubMed ID: 28429355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.
    Visanji NP; Mollenhauer B; Beach TG; Adler CH; Coffey CS; Kopil CM; Dave KD; Foroud T; Chahine L; Jennings D;
    Biomark Med; 2017 Apr; 11(4):359-368. PubMed ID: 28353371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
    Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
    Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease.
    Leclair-Visonneau L; Clairembault T; Volteau C; Chapelet G; Le Dily S; Vavasseur F; Coron E; Préterre C; Neunlist M; Péréon Y; Derkinderen P
    Parkinsonism Relat Disord; 2019 Apr; 61():224-227. PubMed ID: 30262379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease.
    Emmi A; Sandre M; Russo FP; Tombesi G; Garrì F; Campagnolo M; Carecchio M; Biundo R; Spolverato G; Macchi V; Savarino E; Farinati F; Parchi P; Porzionato A; Bubacco L; De Caro R; Kovacs GG; Antonini A
    Mov Disord; 2023 May; 38(5):885-894. PubMed ID: 36847308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain region-dependent differential expression of alpha-synuclein.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    J Comp Neurol; 2016 Apr; 524(6):1236-58. PubMed ID: 26358191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.